Smoking Cessation Aids Market: Global Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Smoking Cessation Aids Market: By Product Type (Nicotine Replacement Therapy, Drugs, Electronic Cigarettes Others) Distribution Channel (Hospital Pharmacies, Online Channel, Retail Pharmacies Others) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

1. Executive Summary
2. Global Smoking Cessation Aids Market Introduction
2.1. Global Smoking Cessation Aids Market – Taxonomy
2.2. Global Smoking Cessation Aids Market –Definitions
2.2.1. Product Type
2.2.2. Distribution Channel
3. Global Smoking Cessation Aids Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Smoking Cessation Aids Market Dynamic Factors – Impact Analysis
3.6. Global Smoking Cessation Aids Market – Competition Landscape
4. Global Smoking Cessation Aids Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Smoking Cessation Aids Market, By Product Type, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1. Nicotine Replacement Therapy
5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Drugs
5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Electronic Cigarettes
5.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Others
5.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
6. Global Smoking Cessation Aids Market Forecast, By Distribution Channel, 2017 – 2021 and Forecast, 2022 – 2028
6.1. Hospital Pharmacies
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Online Channel
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Retail Pharmacies
6.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Others
6.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
7. Global Smoking Cessation Aids Market Forecast, By Region, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.1. North America
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Europe
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Latin America
7.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
7.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Global Smoking Cessation Aids Market – Opportunity Analysis Index, By Product Type, Distribution Channel, and Region, 2022 – 2028
8. North America Smoking Cessation Aids Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.1. By Product Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
8.1.1. Nicotine Replacement Therapy
8.1.2. Drugs
8.1.3. Electronic Cigarettes
8.1.4. Others
8.2. Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
8.2.1. Hospital Pharmacies
8.2.2. Online Channel
8.2.3. Retail Pharmacies
8.2.4. Others
8.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
8.3.1. USA
8.3.2. Canada
8.4. North America Smoking Cessation Aids Market – Opportunity Analysis Index, By Product Type, Distribution Channel, and Country, 2022 – 2028
8.5. North America Smoking Cessation Aids Market Dynamics – Trends
9. Europe Smoking Cessation Aids Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.1. By Product Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Nicotine Replacement Therapy
9.1.2. Drugs
9.1.3. Electronic Cigarettes
9.1.4. Others
9.2. Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Hospital Pharmacies
9.2.2. Online Channel
9.2.3. Retail Pharmacies
9.2.4. Others
9.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.3.1. Germany
9.3.2. UK
9.3.3. France
9.3.4. Spain
9.3.5. Italy
9.3.6. Russia
9.3.7. Poland
9.3.8. Rest of Europe
9.4. Europe Smoking Cessation Aids Market – Opportunity Analysis Index, By Product Type, Distribution Channel, and Country, 2022 – 2028
9.5. Europe Smoking Cessation Aids Market Dynamics – Trends
10. Asia-Pacific Smoking Cessation Aids Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
10.1. By Product Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Nicotine Replacement Therapy
10.1.2. Drugs
10.1.3. Electronic Cigarettes
10.1.4. Others
10.2. Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Hospital Pharmacies
10.2.2. Online Channel
10.2.3. Retail Pharmacies
10.2.4. Others
10.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.3.1. Japan
10.3.2. China
10.3.3. India
10.3.4. ASEAN
10.3.5. Australia & New Zealand
10.3.6. Rest of Asia-Pacific
10.4. Asia-Pacific Smoking Cessation Aids Market – Opportunity Analysis Index, By Product Type, Distribution Channel, and Country, 2022 – 2028
10.5. Asia-Pacific Smoking Cessation Aids Market Dynamics – Trends
11. Latin America Smoking Cessation Aids Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
11.1. By Product Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Nicotine Replacement Therapy
11.1.2. Drugs
11.1.3. Electronic Cigarettes
11.1.4. Others
11.2. Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Hospital Pharmacies
11.2.2. Online Channel
11.2.3. Retail Pharmacies
11.2.4. Others
11.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Argentina
11.3.4. Rest of Latin America
11.4. Latin America Smoking Cessation Aids Market – Opportunity Analysis Index, By Product Type, Distribution Channel, and Country, 2022 – 2028
11.5. Latin America Smoking Cessation Aids Market Dynamics – Trends
12. Middle East and Africa Smoking Cessation Aids Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
12.1. By Product Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Nicotine Replacement Therapy
12.1.2. Drugs
12.1.3. Electronic Cigarettes
12.1.4. Others
12.2. Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Hospital Pharmacies
12.2.2. Online Channel
12.2.3. Retail Pharmacies
12.2.4. Others
12.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.3.1. Gulf Cooperation Council (GCC) Countries
12.3.2. Israel
12.3.3. South Africa
12.3.4. Rest of MEA
12.4. MEA Smoking Cessation Aids Market – Opportunity Analysis Index, By Product Type, Distribution Channel, and Country, 2022 – 2028
12.5. MEA Smoking Cessation Aids Market Dynamics – Trends
13. Competition Landscape 
13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, Distribution Channel & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
13.2.1. Johnson and Johnson
13.2.2. GlaxoSmithKline Plc
13.2.3. Pfizer Inc.
13.2.4. Cipla Inc.
13.2.5. Dr. Reddy’s Laboratories
13.2.6. Novartis AG
13.2.7. NJOY
13.2.8. Takeda Pharmaceuticals Co. Ltd.
13.2.9. Glenmark Pharmaceuticals Ltd.
13.2.10. Philip Morris International Inc.
14. Research Methodology
15. Key Assumptions and Acronyms

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Company Profile

  • Johnson and Johnson
  • GlaxoSmithKline Plc
  • Pfizer Inc.
  • Cipla Inc.
  • Dr. Reddy’s Laboratories
  • Novartis AG
  • NJOY
  • Takeda Pharmaceuticals Co. Ltd.
  • Glenmark Pharmaceuticals Ltd.
  • Philip Morris International Inc.

Description

1. Executive Summary
2. Global Smoking Cessation Aids Market Introduction
2.1. Global Smoking Cessation Aids Market – Taxonomy
2.2. Global Smoking Cessation Aids Market –Definitions
2.2.1. Product Type
2.2.2. Distribution Channel
3. Global Smoking Cessation Aids Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Smoking Cessation Aids Market Dynamic Factors – Impact Analysis
3.6. Global Smoking Cessation Aids Market – Competition Landscape
4. Global Smoking Cessation Aids Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Smoking Cessation Aids Market, By Product Type, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1. Nicotine Replacement Therapy
5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Drugs
5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Electronic Cigarettes
5.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Others
5.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
6. Global Smoking Cessation Aids Market Forecast, By Distribution Channel, 2017 – 2021 and Forecast, 2022 – 2028
6.1. Hospital Pharmacies
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Online Channel
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Retail Pharmacies
6.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Others
6.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
7. Global Smoking Cessation Aids Market Forecast, By Region, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.1. North America
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Europe
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Latin America
7.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
7.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Global Smoking Cessation Aids Market – Opportunity Analysis Index, By Product Type, Distribution Channel, and Region, 2022 – 2028
8. North America Smoking Cessation Aids Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.1. By Product Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
8.1.1. Nicotine Replacement Therapy
8.1.2. Drugs
8.1.3. Electronic Cigarettes
8.1.4. Others
8.2. Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
8.2.1. Hospital Pharmacies
8.2.2. Online Channel
8.2.3. Retail Pharmacies
8.2.4. Others
8.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
8.3.1. USA
8.3.2. Canada
8.4. North America Smoking Cessation Aids Market – Opportunity Analysis Index, By Product Type, Distribution Channel, and Country, 2022 – 2028
8.5. North America Smoking Cessation Aids Market Dynamics – Trends
9. Europe Smoking Cessation Aids Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.1. By Product Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Nicotine Replacement Therapy
9.1.2. Drugs
9.1.3. Electronic Cigarettes
9.1.4. Others
9.2. Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Hospital Pharmacies
9.2.2. Online Channel
9.2.3. Retail Pharmacies
9.2.4. Others
9.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.3.1. Germany
9.3.2. UK
9.3.3. France
9.3.4. Spain
9.3.5. Italy
9.3.6. Russia
9.3.7. Poland
9.3.8. Rest of Europe
9.4. Europe Smoking Cessation Aids Market – Opportunity Analysis Index, By Product Type, Distribution Channel, and Country, 2022 – 2028
9.5. Europe Smoking Cessation Aids Market Dynamics – Trends
10. Asia-Pacific Smoking Cessation Aids Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
10.1. By Product Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Nicotine Replacement Therapy
10.1.2. Drugs
10.1.3. Electronic Cigarettes
10.1.4. Others
10.2. Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Hospital Pharmacies
10.2.2. Online Channel
10.2.3. Retail Pharmacies
10.2.4. Others
10.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.3.1. Japan
10.3.2. China
10.3.3. India
10.3.4. ASEAN
10.3.5. Australia & New Zealand
10.3.6. Rest of Asia-Pacific
10.4. Asia-Pacific Smoking Cessation Aids Market – Opportunity Analysis Index, By Product Type, Distribution Channel, and Country, 2022 – 2028
10.5. Asia-Pacific Smoking Cessation Aids Market Dynamics – Trends
11. Latin America Smoking Cessation Aids Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
11.1. By Product Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Nicotine Replacement Therapy
11.1.2. Drugs
11.1.3. Electronic Cigarettes
11.1.4. Others
11.2. Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Hospital Pharmacies
11.2.2. Online Channel
11.2.3. Retail Pharmacies
11.2.4. Others
11.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Argentina
11.3.4. Rest of Latin America
11.4. Latin America Smoking Cessation Aids Market – Opportunity Analysis Index, By Product Type, Distribution Channel, and Country, 2022 – 2028
11.5. Latin America Smoking Cessation Aids Market Dynamics – Trends
12. Middle East and Africa Smoking Cessation Aids Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
12.1. By Product Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Nicotine Replacement Therapy
12.1.2. Drugs
12.1.3. Electronic Cigarettes
12.1.4. Others
12.2. Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Hospital Pharmacies
12.2.2. Online Channel
12.2.3. Retail Pharmacies
12.2.4. Others
12.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.3.1. Gulf Cooperation Council (GCC) Countries
12.3.2. Israel
12.3.3. South Africa
12.3.4. Rest of MEA
12.4. MEA Smoking Cessation Aids Market – Opportunity Analysis Index, By Product Type, Distribution Channel, and Country, 2022 – 2028
12.5. MEA Smoking Cessation Aids Market Dynamics – Trends
13. Competition Landscape 
13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, Distribution Channel & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
13.2.1. Johnson and Johnson
13.2.2. GlaxoSmithKline Plc
13.2.3. Pfizer Inc.
13.2.4. Cipla Inc.
13.2.5. Dr. Reddy’s Laboratories
13.2.6. Novartis AG
13.2.7. NJOY
13.2.8. Takeda Pharmaceuticals Co. Ltd.
13.2.9. Glenmark Pharmaceuticals Ltd.
13.2.10. Philip Morris International Inc.
14. Research Methodology
15. Key Assumptions and Acronyms

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX